Contingency

Family and Probate attorney with over 15 years experience.

20+ years as both a business executive and also an attorney, I create practical business solutions for legal issues. See Reviews: https://drive.google.com/drive/folders/1EZ4MMM5Tc0hrfwtgl0TN5G7j0QcfYA4q

At DACC.Law, we deliver high-quality, practical legal solutions specifically for entrepreneurs, real estate investors, and growing businesses. With more than 25 years of experience, our firm handles everything from contract drafting and review to entity formation, deal structuring, and risk mitigation. Clients rely on us for clear guidance on regulatory compliance, navigating complex transactions (including multifamily, landlords, developers), resolving disputes efficiently, and protecting their business interests. We combine deep legal expertise with a hands-on, results-oriented approach so you can move forward with confidence.

Professional Experience Neil Belloff is an accomplished business lawyer with over 35 years of business and legal experience, including as Board Member, General Counsel, Chief Compliance Officer, Chief Operating Officer and Corporate Secretary. After law school, Neil joined a boutique law firm in New York City and practiced as a litigator and corporate securities lawyer. Soon thereafter, Neil became a Senior Attorney-Advisor in the Division of Corporation Finance at the U.S. Securities and Exchange Commission in Washington, D.C. responsible for reviewing 1933 Act and 1934 Act documents, coordinating projects with the EPA and DOL, overseeing bankruptcy, reorganization and work-outs, responding to Congressional inquiries, and providing assistance to other SEC divisions and the Department of Justice. Following his tenure with the government, Neil practiced with several NY-based law firms providing legal and business services to public and private enterprises focusing on securities, corporate, employment, IP, licensing, M&A, finance, governance, litigation, compliance and privacy matters. Neil became an in-house attorney in 2003 joining Deutsche Telekom, one of the largest telecommunications companies in the world, as Executive Vice President and US Securities and Corporate Counsel. He joined Celgene Corporation, a publicly listed global biopharmaceutical company, in 2010 and became General Counsel, Chief Compliance Officer and Corporate Secretary of Eloxx Pharmaceuticals, Inc. in 2018 (and Chief Operating Officer in 2020) and General Counsel, Chief Compliance Officer and Corporate Secretary of Acorda Therapeutics, Inc. in 2021. Neil went back to private practice in 2024. Neil has been lead counsel on dozens of IPOs (representing both issuers and underwriters) and multi-billion dollar M&A transactions. His practice includes licensing, structured finance, venture capital, risk assessment, corporate governance, legal and regulatory compliance, pharmaceutical development, and all aspects of corporate, securities, intellectual property, privacy and employment law. Education • J.D. - Quinnipiac University School of Law • LL.M. - Program in Securities Regulation at Georgetown University Law Center • M.A. - New York University • B.A. - Queens College of the City University of New York Admissions • New York, New Jersey, Connecticut • Southern District of New York • Eastern District of New York • District of Connecticut Publications • Frequent conference speaker (FEI, NACD, NIRI, ACC, PLI, MarcusEvans) • Co-authored chapter of NACD report on the Role of Directors in Strategic Planning, member of Blue Ribbon Commission of NACD • Authored various articles on securities, litigation and governance topics • Featured in Vanguard Law Magazine - https://www.vanguardlawmag.com/case-studies/neil-belloff-acorda-therapeutics/ Board Memberships • Former Board Member | Private computer network and software development company sold to NASDAQ listed company • Former Board Member | NASDAQ listed location-based entertainment company

I am a solo practitioner that runs my own legal practice. I am currently licensed in 16 states and I'm working to expand that reach.

Walid J. Tamari, founder and named member of Tamari Law Group, LLC, is widely recognized as one of the nation's top litigators. In 2018, Mr. Tamari was one of only 25 attorneys in the United States to be recognized by the prestigious National Law Journal as a Trailblazer Lawyer. The publication features lawyers who have “shown a deep passion and perseverance of their mission, having achieved remarkable successes along the way.” In addition, America's Top 100 Attorneys® and the National Trial Lawyers have included Mr. Tamari in their top 100 Illinois attorneys lists and the Business Tort Trial Lawyers Association has also selected Mr. Tamari in its “Illinois Top 10” list. Further, for several years, Benchmark Litigation: The Definitive Guide to America's Leading Litigation Firms has chosen Tamari Law Group as one of approximately 25 ranked litigation firms in Illinois. Mr. Tamari is also the past national chair of the Commercial Law League of America's complex commercial litigation committee, a committee comprised of attorneys throughout the nation who practice complex litigation. A distinguished litigator, Mr. Tamari represents clients in high-stakes and high profile civil litigation. He provides clients with result-oriented legal advice and representation in a wide-range of disputes, including claims relating to breach of contract, negligence, business tort and pharmaceutical liability litigation. Mr. Tamari has appeared on CBS News, NBC News, WGN News and Fox News and has been quoted in, among other publications, Forbes, Crain's Chicago Business, Chicago Tribune and the Chicago Sun-Times. Mr. Tamari also teaches entrepreneurship law at Loyola University of Chicago's Graduate School of Business. Committed to giving back to the community, Mr. Tamari has established scholarships at the University of Chicago Laboratory Schools and Loyola University of Chicago's Graduate School of Business. He has served on national advisory boards at Loyola University of Chicago, the University of Chicago Laboratory Schools and Northwestern Medical Faculty Foundation's Neurosurgery Council.